scispace - formally typeset
Journal ArticleDOI

Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy

Reads0
Chats0
TLDR
carry-over of both the post-injection augmentation and dark phase reduction of locomotion was revealed during amphetamine retest 8 days following discontinuation of daily d-amphetamine injections, indicating the importance of their concurrent evaluation, especially during chronic studies.
Abstract
The competitive relationship between d-amphetamine induced stereotypy and locomotor activity indicates the importance of their concurrent evaluation, especially during chronic studies. Repeated injection of 0.5, 1.0, 2.5, 5.0, or 7.5 mg/kg d-amphetamine for 36 successive days, in rats continuously exposed to the experimental chambers, produced a progressive augmentation in stereotypy and/or locomotion (depending on dose) during the 3–4 hr interval following injections (post-injection phase). In contrast, dark phase locomotor activity (8–20 hr after each daily injection) was maximally reduced (30–40% of controls) after the first injection of either 5.0 or 7.5 mg/kg d-amphetamine and gradually declined to this level with repeated injection of 1.0 and 2.5 mg/kg. Carry-over of both the post-injection augmentation and dark phase reduction of locomotion was revealed during amphetamine retest 8 days following discontinuation of daily d-amphetamine injections. Possible mechanisms underlying these behavioral alterations are discussed.

read more

Citations
More filters
Journal ArticleDOI

Short-term regulation of hydroxylase cofactor activity in rat brain.

TL;DR: A conformational stability‐dependent variable degree of stoichiometric coupling between quinonoid dihydropteridine reductase and tyrosine hydroxylase is proposed as a short‐latency influence on hydroxyase cofactor levels.
Journal ArticleDOI

Alterations in β-endorphin-induced locomotor activity in morphine-tolerant rats

TL;DR: The results suggest that the same underlying mechanisms subserve the behavioral effects produced by opiates and opioid peptides.
Journal ArticleDOI

A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP ( dl -3-[3-hydroxyphenyl]-N-n-propylpiperidine)

TL;DR: 3-PPP-pretreated mice were more sensitive to the activating effects ofd- methamphetamine, and this increased sensitivity was blocked by pretreatment with reserpine, which may be due to a reduction in the feedback control exerted by the DA released by thed-amphetamine due to the DA autoreceptors having become subsensitive.
Journal ArticleDOI

Effect of chlorpromazine on mouse ambulatory activity sensitization caused by (+)‐amphetamine

TL;DR: The development of sensitization to the ambulation‐increasing effect of (+)‐amphetamine was found to be dose‐dependently inhibited when 1 or 2 mg kg−1 chlorpromazine was administered concomitantly, and the sensitization was almost completely suppressed when co‐administered with 4 mg kg‐1 chlor Promazine.
References
More filters
Journal Article

Antiamphetamine effects following inhibition of tyrosine hydroxylase

TL;DR: The antiamphetamine effects of α-MT and other tyrosine hydroxylase inhibitors suggest that a critical level of norepinephrine at the receptor is required for amphetamine to exert its customary effects.
Journal ArticleDOI

Role of Catecholamines in the Amphetamine Excitatory Response

A. Randrup, +1 more
- 30 Jul 1966 - 
TL;DR: The advent of α-methyl para-tyrosine3 (α-MPT), which inhibits the in vivo synthesis of 3,4-dihydroxyphenylalanine (DOPA)—the physiological precursor of the catecholamines—offers a new way of investigating this problem.
Related Papers (5)